Efficacy and safety of 25 and 50 μg desmopressin orally disintegrating tablets in Japanese patients with nocturia due to nocturnal polyuria: Results from two phase 3 studies of a multicenter randomized double‐blind placebo‐controlled parallel‐group development program

This study assessed the efficacy and safety of desmopressin orally disintegrating tablets (ODTs) in Japanese males (50 and 25 μg) and females (25 μg) with nocturia due to nocturnal polyuria (NP). Two Phase 3 randomized double‐blind placebo‐controlled studies of 342 males and 190 females with nocturi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Osamu, Juul, Kristian V., Falahati, Ali, Yoshimura, Toru, Imura, Futoshi, Kitamura, Mikiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Asia Pty Ltd 2019
Materias:
Original Articles ‐ Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004048/
https://www.ncbi.nlm.nih.gov/pubmed/31397969
http://dx.doi.org/10.1111/luts.12276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004048/
https://www.ncbi.nlm.nih.gov/pubmed/31397969
http://dx.doi.org/10.1111/luts.12276

Ejemplares similares